Chandan Healthcare Ltd

Chandan Healthca Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Chandan Healthcare Ltd

₹ 321 -0.03%
05 Dec - close price
chandandiagnostic.com NSE - SME: CHANDAN
About

Incorporated in September 2003, Chandan Healthcare Limited runs diagnostic centers in North India with pathology and radiology testing services.[1]

Key Points

Business Profile[1]
Chandan Healthcare Limited operates a diagnostic network in North India that offers pathology and radiology testing services. The company has a presence in Uttar Pradesh, Uttarakhand, and Jaipur (Rajasthan), with a strong network of labs, satellite centers, and collection points

Website NSE - SM
  • Market Cap ₹ 785 Cr.
  • Current Price ₹ 321
  • High / Low ₹ 358 / 140
  • Stock P/E 28.9
  • Book Value ₹ 56.5
  • Dividend Yield 0.00 %
  • ROCE 28.8 %
  • ROE 27.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.5%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
  • Working capital days have increased from 17.8 days to 75.4 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Healthcare Healthcare Healthcare Services Healthcare Service Provider

Edit Columns
Loading peers table ...

Half Yearly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2024 Sep 2024 Mar 2025 Sep 2025
92 110 120 136
78 91 98 108
Operating Profit 14 20 21 28
OPM % 15% 18% 18% 21%
1 1 1 2
Interest 1 2 2 3
Depreciation 2 3 4 5
Profit before tax 11 15 17 22
Tax % 24% 27% 27% 26%
8 11 12 17
EPS in Rs 4.23 5.32 4.72 6.38
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 TTM
120 137 177 230 255
117 128 150 189 206
Operating Profit 2 9 26 41 50
OPM % 2% 7% 15% 18% 19%
0 0 1 2 3
Interest 2 2 3 5 5
Depreciation 2 2 3 7 8
Profit before tax -1 5 21 32 39
Tax % 3% 28% 24% 27%
-1 3 16 24 29
EPS in Rs -0.56 1.68 8.14 9.07 11.10
Dividend Payout % 0% 0% 0% 0%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: 24%
TTM: 26%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: 180%
TTM: 42%
Stock Price CAGR
10 Years: %
5 Years: %
3 Years: %
1 Year: %
Return on Equity
10 Years: %
5 Years: %
3 Years: 30%
Last Year: 27%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025 Sep 2025
Equity Capital 20 20 20 24 24
Reserves 4 7 21 98 114
17 21 36 48 67
41 49 41 40 68
Total Liabilities 82 98 118 211 273
29 33 48 76 91
CWIP 0 0 0 4 5
Investments 6 7 3 1 47
46 58 66 129 130
Total Assets 82 98 118 211 273

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
6 4 1 -29
-11 -6 -15 -36
3 2 16 67
Net Cash Flow -1 0 2 2

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 88 63 59 74
Inventory Days 46 71 96 126
Days Payable 185 251 102 102
Cash Conversion Cycle -51 -117 53 98
Working Capital Days -11 -21 -1 75
ROCE % 16% 37% 29%

Shareholding Pattern

Numbers in percentages

4 Recently
Mar 2025Sep 2025
49.43% 49.47%
3.86% 1.11%
6.32% 5.02%
40.38% 44.41%
No. of Shareholders 8971,307

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

DRHP

Credit ratings

Concalls

  • Dec 2025
    Transcript PPT
  • Nov 2025
    Transcript
    AI Summary
    PPT REC
  • Aug 2025
    Transcript
    AI Summary
    PPT